" /> Ectodermal dysplasia and immunodeficiency 2 - CISMeF





Preferred Label : Ectodermal dysplasia and immunodeficiency 2;

Symbol : EDAID2;

CISMeF acronym : EDAID2;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Ectodermal dysplasia, anhidrotic, with t-cell immunodeficiency, autosomal dominant; Ectodermal dysplasia, hypohidrotic, with immunodeficiency 2; Ectodermal dysplasia, anhidrotic, with immunodeficiency 2;

Description : Mutations in the NFKBIA gene result in functional impairment of NFKB1 (164011), a master transcription factor required for normal activation of immune responses. Interruption of NFKB1 signaling results in decreased production of proinflammatory cytokines and certain interferons, rendering patients susceptible to infection (McDonald et al., 2007).;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the nuclear factor kappa-B inhibitor, alpha gene (NFKBIA, 164008.0001);

Prefixed ID : #612132;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.